Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma (Q40669502)
scientific article published on May 1996
Language:
(P31) (Q13442814)
(P304) 1552-1557
(P407) (Q1860)
(P433) 5
(P478) 14
(P577) Wednesday, May 1, 1996
(P1433) (Q400292)
(P1476) "Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma" (language: en)
(P2093) A P Kudelka
D Tresukosol
C L Edwards
R S Freedman
C Levenback
P Chantarawiroj
C Gonzalez de Leon
E E Kim
T Madden
B Wallin
M Hord
C Verschraegen
M Raber
J J Kavanagh
other details
description scientific article published on May 1996

External Links